Correvio Pharma Corp. Accounts Receivable, Allowance for Credit Loss, Current
Correvio Pharma Corp. had Accounts Receivable, Allowance for Credit Loss, Current of $92.00 thousand as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2020-04-30
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss, Current $92.00K.
- 2018-12-31: Accounts Receivable, Allowance for Credit Loss, Current $102.00K.
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss, Current $125.00K.
- 2016-12-31: Accounts Receivable, Allowance for Credit Loss, Current $97.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2019-12-31 | $92.00K 20-F · filed 2020-04-30 |
| 2018-12-31 | $102.00K 20-F · filed 2020-04-30 |
| 2017-12-31 | $125.00K 40-F · filed 2019-03-13 |
| 2016-12-31 | $97.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $424.00K 40-F · filed 2017-03-29 |
| 2014-12-31 | $596.00K 40-F · filed 2016-03-29 |
| 2013-12-31 | $325.00K 40-F · filed 2015-03-27 |
| 2012-12-31 | $0.00 40-F/A · filed 2014-04-30 |